Skip to main content

Is Umbilical Cord Tissue Toxicology the Right Choice for Your Hospital?

From the 2020 Joint Annual Meeting (June 30, 2020)
Presented by Joshua Hayden, PhD, DABCC, FAACC
This session will outline factors laboratorians should consider when evaluating a switch to umbilical cord toxicology. In particular, it will discuss the analytic performance relative to urine and meconium, the importance of turnaround time, and important considerations specific to the population served (rates of abuse, drugs abuse, etc).

LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to:

  1. Evaluate the performance of umbilical cord toxicology relative to meconium and urine for the detection of drug exposure.
  2. Describe the importance of turnaround time for this testing.
  3. Identify factors which make umbilical cord testing more or less appropriate for their hospital, especially with respect to rates of abuse and the drugs abused.

CE ACCREDITATION
This recorded presentation is P.A.C.E. ® accredited. The instruction level for this activity is Intermediate. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of Chemistry will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

LEVEL OF INSTRUCTION
This intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.